Dr. Osman Kibar is an entrepreneur and an inventor, with numerous successful start-ups under his belt. Dr. Kibar is the Founder and the CEO of Samumed since its inception in 2008. Prior to Samumed, he was the scientific founder of Genoptix (an oncology diagnostics company), which went public in 2007 (NASDAQ: GXDX) and was later acquired by Novartis in 2011. Dr. Kibar was also a co-founder of E–Tenna, whose assets relating to antennas were acquired by Titan and assets relating to microprocessors by Intel. He was a vice president at Pequot Capital’s venture capital and private equity team.
Dr. Kibar received his M.S. and Ph.D. from the University of California, San Diego, specializing in biophotonics and optoelectronics, a B.S. in electrical engineering from Caltech, and a B.A. in mathematical economics from Pomona College.